SPOTLIGHT REVIEW Research priorities in sarcomeric cardiomyopathies
نویسندگان
چکیده
Department of Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, van der Boechorststraat 7, 1081BT Amsterdam, The Netherlands; ICIN-Netherlands Heart Institute, Utrecht, The Netherlands; Brigham and Women’s Hospital, Cardiology, Boston, MA, USA; Department of Medicine and Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA; Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy; Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Germany
منابع مشابه
SPOTLIGHT REVIEW Targets for therapy in sarcomeric cardiomyopathies
Department of Medicine and Cellular and Molecular Medicine, University of Arizona, 1656 East Mabel Street, MRB 312, Tucson, AZ 85724-5217, USA; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany; Department of Pharmacology, Univ...
متن کاملSarcomeric proteins and inherited cardiomyopathies.
Over the last two decades, a large number of mutations have been identified in sarcomeric proteins as a cause of hypertrophic, dilated or restrictive cardiomyopathy. Functional analyses of mutant proteins in vitro have revealed several important functional changes in sarcomeric proteins that might be primarily involved in the pathogenesis of each cardiomyopathy. Creation of transgenic or knock-...
متن کاملTargets for therapy in sarcomeric cardiomyopathies.
To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molecular insights that can be useful for the design of novel specific drugs suitable for clinical use...
متن کاملContribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes
Secondary shifts develop in post-translational phosphorylation of sarcomeric proteins in multiple animal models of inherited cardiomyopathy. These signaling alterations together with the primary mutation are predicted to contribute to the overall cardiac phenotype. As a result, identification and integration of post-translational myofilament signaling responses are identified as priorities for ...
متن کاملModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
One of the obstacles to a better understanding of the pathogenesis of human cardiomyopathies has been poor availability of heart-tissue samples at early stages of disease development. This has possibly changed by the advent of patient-derived induced pluripotent stem cell (hiPSC) from which cardiomyocytes can be derived in vitro. The main promise of hiPSC technology is that by capturing the eff...
متن کامل